Skip to content

Author

Ling-Ling Liu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Targeting SERPINB5 and MSLN for Pancreatic Cancer Therapy

Simple Summary Pancreatic cancer (PC) is a leading cause of cancer-related death, with no effective therapy for curing late-stage PC. Developing effective therapeutic strategies is an emergent unmet need. SERPINB5 is non-inhibitory toward serine proteases, and mesothelin (MSLN) is a tumor-associated antigen. SERPINB5 a...

Jing-Hui Sun, Ling-Ling Liu, Rhyston Broadhurst et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.